chartexchange

Phathom Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire Inc. | Oct 29, 2026 7:00 AM EDT

FLORHAM PARK, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, today reported financial results for the third quarter ended September 30, 2026, and provided a business update.

Read original article